MaxCyte (LON:MXCT) Share Price Passes Above 50-Day Moving Average – What’s Next?

MaxCyte, Inc. (LON:MXCT) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 0.98 and traded as high as GBX 1.17. MaxCyte shares last traded at GBX 1.14, with a volume of 563,557 shares changing hands.

MaxCyte Price Performance

The stock has a 50 day moving average price of GBX 0.98 and a 200-day moving average price of GBX 1.07. The company has a debt-to-equity ratio of 9.70, a current ratio of 12.39 and a quick ratio of 14.38. The stock has a market capitalization of £1.21 million, a price-to-earnings ratio of -0.03 and a beta of 1.13.

About MaxCyte

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.